Cite
MLA Citation
J.J.M. Kwakman et al.. “Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group.” European journal of cancer, vol. 72, n.d., pp. S5–. http://access.bl.uk/ark:/81055/vdc_100041522033.0x000011